Applicant, as named in the Orange Book
Evofem Inc
Next listed expiry: Phexx on 15 Mar 2033. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Phexx NDA 208352 citric acid; lactic acid; potassium bitartrate | 15 Mar 2033 patent |
| Solosec NDA 209363 secnidazole | 11 Dec 2041 patent, carve-out possible |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.